aXichem
1.215 SEK +1.25%Be the first to follow this company
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
AXIC A
Daily low / high price
1.165 / 1.225
SEK
Market cap
48.97M SEK
Turnover
17.45K SEK
Volume
14K
Financial calendar
Interim report
27.08.2024
Interim report
28.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
LMK Bolagen | 12.9 % | 12.9 % |
Manakin Ltd | 8.9 % | 8.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools